{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:01:19Z","timestamp":1791378079573,"version":"4.3.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008890","name":"University of Dundee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaci.2024.11.024","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:52:45Z","timestamp":1732665165000},"page":"834-842.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effects of dupilumab on mannitol airway hyperresponsiveness in uncontrolled severe asthma"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-9868","authenticated-orcid":false,"given":"Kirsten E.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"RuiWen Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-2014","authenticated-orcid":false,"given":"Brian J.","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.11.024_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1081\/JAS-120028582","article-title":"Does bronchial hyperresponsiveness in asthma matter?","volume":"41","author":"Currie","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2024.11.024_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaip.2016.11.030","article-title":"Airway hyperresponsiveness in asthma: measurement and clinical relevance","volume":"5","author":"Nair","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.11.024_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1183\/09031936.03.00008403","article-title":"Indirect airway challenges","volume":"21","author":"Joos","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.11.024_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/20734735.003111","article-title":"Bronchial challenge tests: usefulness, availability and limitations","volume":"8","author":"Anderson","year":"2011","journal-title":"Breathe"},{"key":"10.1016\/j.jaci.2024.11.024_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2022.10.028","article-title":"Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma","volume":"151","author":"Chan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.024_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.11.024_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.11.024_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12325-018-0702-4","article-title":"Liberty Asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma","volume":"35","author":"Busse","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2024.11.024_bib9","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.11.024_bib10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1034\/j.1398-9995.2003.00226.x","article-title":"Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate","volume":"58","author":"Currie","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.11.024_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S1081-1206(10)61396-8","article-title":"Comparative cutoff points for adenosine monophosphate and methacholine challenge testing","volume":"93","author":"Fardon","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.024_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.11-1748","article-title":"A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial","volume":"141","author":"Lipworth","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.11.024_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.11.024_bib14","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.11.024_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.anai.2017.12.026","article-title":"Does the asthma visual analog scale relate to the Asthma Control Questionnaire?","volume":"120","author":"Jabbal","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.024_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2024.11.024_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2222.2009.03381.x","article-title":"The minimal clinically important difference in allergic rhinitis","volume":"40","author":"Barnes","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.11.024_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1399-3003.1999.14a06.x","article-title":"What are minimal important changes for asthma measures in a clinical trial?","volume":"14","author":"Santanello","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.11.024_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4193\/Rhino10.097","article-title":"Minimal clinically important differences in nasal peak inspiratory flow","volume":"49","author":"Timperley","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.11.024_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/alr.22028","article-title":"Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis","volume":"7","author":"Chowdhury","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.11.024_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s40629-016-0006-7","volume":"26","author":"Klimek","year":"2017","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaci.2024.11.024_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100776","article-title":"Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps","volume":"16","author":"Braid","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2024.11.024_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2019.10.037","article-title":"IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways","volume":"145","author":"Manson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.11.024_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anai.2021.06.007","article-title":"Impact of nasal polyps on endotype and phenotype in patients with moderate to severe asthma","volume":"127","author":"Chan","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.11.024_bib25","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.jaip.2021.07.023","article-title":"The choice of biologics in patients with severe chronic rhinosinusitis with nasal polyps","volume":"9","author":"Lipworth","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.11.024_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1081-1206(10)61327-0","article-title":"Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge","volume":"94","author":"Lipworth","year":"2005","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924012752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924012752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:17:19Z","timestamp":1744723039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924012752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0091674924012752"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.11.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dupilumab on mannitol airway hyperresponsiveness in uncontrolled severe asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}